U.S. Healthtech Stock News

Following dovish remarks by Federal Reserve Chair Jerome Powell at the Jackson Hole symposium, investor sentiment shifted on expectations of possible interest rate cuts, supporting regional banks including First Bancorp. This event highlighted the sensitivity of regional banks to shifts in monetary policy, as lower borrowing costs can directly influence lending activity and profitability. We'll explore how expectations of interest rate changes are reshaping the investment narrative for First...

Flex LNG (NYSE:FLNG) has been busy lately, and investors are paying attention. In quick succession, the company announced a $15 million share buyback, fresh sale and leaseback vessel deals, a new term loan to improve financing costs, and a move to delist from the Oslo Stock Exchange so its stock will trade exclusively on the NYSE. For anyone following FLNG, these developments not only highlight management’s focus on capital returns and financial flexibility but also raise timely questions...

It’s not every day that Keurig Dr Pepper (KDP) draws this much attention, but its shares have quietly climbed nearly 11% so far this year. With investors keeping a watchful eye on consumer staples during uncertain economic times, even smaller stock moves spark debates about whether there’s a hidden story behind the ticker. For KDP, that conversation often returns to its mix of steady revenue growth and recent earnings progress. Taking a broader view, Keurig Dr Pepper’s stock has edged only...

Provident Financial Services, along with several regional bank peers, saw increased investor interest following dovish comments from Federal Reserve Chair Jerome Powell at the recent Jackson Hole symposium, signaling the possibility of future interest rate cuts amid moderating inflation and low unemployment. Further supporting sentiment, analysts raised earnings estimates for Provident Financial Services over the last 60 days and assigned it a top Zacks Rank, highlighting a shift in outlook...

It is not every day that you see a stock jump more than 16% in a single day, but that is exactly what Cipher Mining (CIFR) just did following a surge of bullish analyst recommendations. Several Wall Street firms upgraded their stance on the company, leading to a wave of new Buy ratings and increased attention to its earnings outlook. With Zacks Research and others voicing newfound optimism about future prospects, investors now face the real question: does this rally have staying power, or is...

UiPath (PATH) has seen its stock catch a wave of renewed interest, with shares climbing roughly 3% on the day in otherwise quiet trading. There is no headline-grabbing announcement or breakthrough product launch, which might leave some investors wondering why the stock is moving at all. Sometimes, these quieter surges prompt a closer look: is the market sensing something beneath the surface, or is this simply the ebb and flow of investor sentiment? Looking at the bigger picture, UiPath’s...

If you have been watching NVIDIA's stock lately and wondering whether now is the right time to buy, hold, or cash in, you are far from alone. NVIDIA's shares have been on an extraordinary ride, with the stock climbing nearly 36% over the last year and an astonishing 996% over the past three years. The company’s performance consistently tops headlines, and for good reason: its blend of innovation and market dominance in AI and semiconductors keeps investors talking. But no story is ever...

If you are debating whether to hold onto Abbott Laboratories stock or make a new investment, you are hardly alone. The company has caught the market’s attention, not just for its role in healthcare, but also for its stock’s recent moves. After a steady rise, Abbott’s share price has climbed over 16% year-to-date and nearly 20% over the past year. This is a sign that investors are responding well to its stability and growth potential. Shorter-term returns have also been positive, with a 5%...

In recent days, analysts voiced concerns that Donnelley Financial Solutions faces underlying challenges, such as declining sales and profitability headwinds, which may not be reflected in bullish coverage by some investment banks. This spotlight on potential conflicts of interest and misaligned incentives highlights the importance of weighing risks that could impact the company's long-term operational performance. We’ll now examine how heightened skepticism over fundamentals and analyst...

Thinking about what to do with Palo Alto Networks stock? You are not alone. After all, it is a favorite in the cybersecurity space and a name that tends to spark debate every earnings season. Maybe you have noticed the uptick in its price lately, with shares rising nearly 1.4% in a single day and gaining almost 5% this week. Yet, looking back, the past month has been a bit bumpier, with shares dropping about 6.7%. The longer-term picture is even more nuanced. Still, the company is sitting on...

In recent news, Federated Hermes has benefited from increased institutional inflows and growth in assets under management, driven in part by expanding into alternative investments and technology upgrades. The firm's focus on digital transformation and selective acquisitions sets it up to potentially maintain margins even while facing higher short-term costs. These trends highlight how Federated Hermes is adapting to industry-wide shifts by capitalizing on evolving client needs and investing...

Columbia Banking System, Inc. recently declared a quarterly cash dividend of US$0.36 per share, set for payment on September 15, 2025, to shareholders of record as of August 29, 2025, and also announced its participation in the Barclays Global Financial Services Conference for September 10, 2025. Improved investor sentiment toward regional banks followed dovish remarks by Federal Reserve Chair Jerome Powell at Jackson Hole, with Columbia Banking System also receiving recognition through its...

Thinking About Vertex Pharmaceuticals Stock? Here’s What You Need to Know If you’ve been watching Vertex Pharmaceuticals lately, you’re definitely not alone. With the stock trading at $395.12, investors are wondering if the recent ups and downs signal an opportunity or a warning sign. Over the past month, Vertex has slipped around 17%. This follows multi-year returns that would make most biotechs envious. In fact, despite this recent dip, Vertex has delivered an impressive 40% total return...

Thinking about what to do with Quest Diagnostics stock? You are not alone. Whether you are a seasoned shareholder or just watching from the sidelines, recent market movements have made this healthcare name hard to ignore. In the past year alone, Quest Diagnostics has delivered a total return around 20%, and the stock is up about 19% year-to-date. That is not bad for a company many still see as a mainstay in the diagnostics sector. Over the past five years, shares have practically doubled,...

Woodside Energy has appointed Cushman & Wakefield to deliver integrated real estate solutions across its global office portfolio in a five-year agreement spanning 14 countries, including regions in Asia Pacific, Europe, the Middle East & Africa, Latin America, and North America. This represents an expansion of a long-standing relationship and marks Cushman & Wakefield's first Global Occupier Services mandate with a client headquartered in Perth, illustrating the company's ongoing emphasis on...

If you have been following Sysco’s stock lately, you have probably noticed its steady climb and wondered whether it is time to jump in, hold tight, or take profits off the table. The company’s shares have advanced nearly 6.5% this year despite some bumps, and it is sitting just shy of analysts’ price targets. For those weighing their next move, it is not just about momentum; it is about whether Sysco is still a good value after the gains, especially now that consumer staples in general are...

If you are staring at Gilead Sciences and wondering whether it is time to buy, hold, or sell, you are not alone. The stock has delivered a solid ride lately, with a 25% year-to-date gain and a 54% total return over the past year. Even with some short-term volatility, including a dip over the last week, the longer-term chart looks encouraging for those seeking exposure to biotech leaders. A closer look at recent headlines reveals some of the intricacies underlying these moves. News that CVS...

If you are following United Natural Foods (UNFI), the latest labor news may have you weighing your next move carefully. With over 300 warehouse workers in Sarasota securing a five-year deal that delivers up to an $8-per-hour wage increase, new Teamsters health care, and a pension plan, operational costs are likely to shift. This contract represents the latest in a series of union victories at the company, following similar agreements for drivers and warehouse teams across several states. For...

Recently, analysts raised their earnings estimates for Textron Inc., citing the company's strong valuation metrics and positive outlook connected to its well-known brands like Bell Helicopter and Cessna Aircraft Company. This shift in analyst sentiment appears to be drawing increased attention from value-focused investors seeking opportunities in the aerospace and defense sector. We'll now explore how these upward earnings estimate revisions may impact Textron's broader investment narrative,...

ESCO Technologies (ESE) just raised its full-year revenue guidance for 2025, a move that is sure to catch the attention of investors weighing what is next for the stock. Despite reporting a drop in third quarter net income, management’s increase in revenue expectations signals confidence in the business, especially as the Maritime segment is integrated. For those tracking the company’s story, this new forecast highlights the potential impact of trends like grid modernization and rising...

Following remarks from Federal Reserve Chair Jerome Powell hinting at possible interest rate cuts, investors responded with optimism about future borrowing costs and economic activity, particularly in sectors tied to consumer and housing demand. This development holds particular relevance for Mohawk Industries, as lowered interest rates can support higher home buying and remodeling activity, a central factor in the company's market environment. We'll examine how rising expectations of lower...

Earlier this month, CTS Corporation’s Board of Directors declared a US$0.04 per share cash dividend payable on October 24, 2025, to shareholders of record as of September 26, 2025. While the dividend was affirmed, the company’s most recent quarter saw a substantial earnings miss driven by weaker performance in key divisions and acquisition integration costs. We'll explore how the earnings miss and ongoing integration challenges could influence the outlook for CTS’s long-term investment...

On August 18, 2025, CoreCivic announced that CEO Damon T. Hininger will step down in January 2026, with President and COO Patrick Swindle set to assume the CEO role and join the company's Board following Hininger's resignation. This leadership change coincided with the resumption of operations at CoreCivic's West Tennessee Detention Facility under a new contract with the City of Mason and U.S. Immigration and Customs Enforcement, expected to contribute US$30 million to US$35 million in...

If you are thinking about what to do with International Business Machines stock, you are definitely not alone. IBM has found its way back into the spotlight after a remarkable run over the past year, climbing 26.9% in total return. Even if you only started following the stock this year, you have seen a strong 10% return year to date. This easily outpaces plenty of household names in tech. It is not just a sudden spike either. IBM’s three- and five-year total returns both come in above 100%,...